研究者
J-GLOBAL ID：201601009547822170
更新日: 2023年06月07日
山田 哲平
ヤマダ テッペイ | TEPPEI YAMADA
所属機関・部署：
職名：
講師
研究分野 (2件)：
消化器外科学
, 消化器外科学
競争的資金等の研究課題 (5件)：
- 2022 - 2026 消化器がんに対する免疫チェックポイント阻害剤治療の腫瘍免疫学的評価とその意義
- 2021 - 2024 アミノ酸プロファイルによるがん免疫微小環境の代謝リプログラミング評価とがん免疫治療患者層別化技術の開発
- 2018 - 2023 次世代がん治療研究所
- 2018 - 2022 免疫チェックポイント阻害剤の効果予測、治療選択に有用なバイオマーカーの同定
- 2019 - 2021 がんの進化論
論文 (40件)：
-
Hayashi T, Yoshida Y, Yamada T, Tanaka K, Shimaoka H, Kajitani R, Munechika T, Nagano H, Matsumoto Y, Komono A, et al. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer. Cancer Med. 2022
-
Xinyuan Lei, Zhanpeng Ou, Zhaohui Yang, Jianglong Zhong, Yanliang Zhu, Jing Tian, Jiannan Wu, Heran Deng, Xinyu Lin, Yu Peng, et al. A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3- specific CAR-T Cells in Solid Tumors. Clin Cancer Res. 2021. 27. 3757-3771
-
Theodoros Michelakos, Lei Cai, Vincenzo Villani, Francesco Sabbatino, Filippos Kontos, Carlos Fernández-Del Castillo, Teppei Yamada, Azfar Neyaz, Martin S Taylor, Vikram Deshpande, et al. Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy. J Natl Cancer Inst. 2021. 113. 2. 182-191
-
Yoshihiro Uchino, Daisuke Muroya, Munehiro Yoshitomi, Shigeki Shichijo, Akira Yamada, Tetsuro Sasada, Teppei Yamada, Koji Okuda, Kyogo Itoh, Shigeru Yutani. Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer. Mol Clin Oncol. 2021. 14. 2. 39
-
Tanaka K, Yoshida Y, Yamada T, Hayashi T, Shimaoka H, Yoshimura F, Kajitani R, Munechika T, Matsumoto Y, Nagano H, et al. Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer. Sci Rep. 2021. 11. 1. 13263
もっと見る
MISC (9件)：
-
Tomohiro Kurokawa, Teppei Yamada, Lei Cai, Soldano Ferrone, Cristina R. Ferrone. B7-H3-Specific Chimeric-Antigen Receptor T-Cell-Based Immunotherapy for Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons. 2018. 227. 4. S236
-
Naoya Aisu, Yoichiro Yoshida, Akira Komono, Teppei Yamada, Daibo Kojima, Toshiyuki Mera, Syu Tanimura, Yuichi Yamashita. Perioperative chemotherapy with S-1 plus oxaliplatin (SOX) for stage III colorectal cancer patients. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 4
-
Taisuke Matsuoka, Yoichiro Yoshida, Ai Mogi, Teppei Yamada, Naoya Aisu, Daibo Kojima, Syu Tanimura, Tomoko Koganemaru, Fumiaki Kiyomi, Yuichi Yamashita. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy. ANNALS OF ONCOLOGY. 2015. 26. 114-114
-
Yoichiro Yoshida, Kenichiro Ogura, Akira Hiratsuka, Naoya Aisu, Yamada Teppei, Kojima Daibo, Syu Tanimura, Kentaro Ogata, Syuji Hara, Yuichi Yamashita. Potential of the 5-fluorouracil dose-escalation method for dihydropyrimidine dehydrogenase-deficient patients. ANNALS OF ONCOLOGY. 2015. 26. 140-140
-
Naoya Aisu, Yoichiro Yoshida, Teppei Yamada, Taisuke Matsuoka, Daibo Kojima, Syu Tanimura, Seiichiro Hoshino, Ai Mogi, Tomoko Koganemaru, Mayumi Oda, et al. The difference between the subjective and objective evaluation of oxaliplatin-induced vascular pain due to administer chemotherapy via peripheral vein. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 3
もっと見る
書籍 (1件)：
-
Cancer Immunotherapy Principles and Practice
Springer 2017
講演・口頭発表等 (22件)：
-
当院における切除不能進行・再発胃癌に対するNivolumab療法を使用した治療戦略
(第75回日本消化器外科学会定期学術総会 2020)
-
当院における切除不能進行・再発胃癌に対するNivolumab療法と今後の展望
(第45回日本外科系連合学会学術集会 2020)
-
当院での切除不能進行・再発胃癌に対するNivolumab療法の現状
(第17回日本免疫治療学会学術集会 2020)
-
The Validity of Evaluations for Chemotherapy-Induced Peripheral Neuropathy (CIPN)
(2019 European Society for Medical Oncology (ESMO) CONGRESS 2019)
-
The impact of islet purity on metabolic outcome after islet transplantation via portal vein
(17th World Congress of the INTERNATIONAL PANCREAS & ISLET TRANSPLANT ASSOCIATION 2019)
もっと見る
学位 (1件)：
委員歴 (1件)：
- 2019/04/01 - 日本免疫治療学会 運営委員(ジュニア)
受賞 (1件)：
- 2016/03 - 日本消化器病学会(JSGE) 若手研究者のための留学支援制度採択
前のページに戻る
